The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient
Open accessAbstract
VP1 sequences were determined for poliovirus type 1 isolates obtained over a 189-day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in antibody formation). The isolate from the first sample, taken 11 days after onset of paralysis, contained two poliovirus populations, differing from the Sabin 1 vaccine strain by ∼10%, differing from diverse type 1 wild polioviruses by 19 to 24%, and differing from each other by 5.5% of nucleotides. Specimens taken after day 11 appeared to contain only one major poliovirus population. Evolution of VP1 sequences at synonymous third-codon positions occurred at an overall rate of ∼3.4% per year over the 189-day period. Assuming this rate to be constant throughout the period of infection, the infection was calculated to have started ∼9.3 years earlier. This estimate is about the time (6.9 years earlier) the patient received his last oral poliovirus vaccine dose, approximately 2 years before the diagnosis of immunodeficiency. These findings may have important implications for the strategy to eliminate poliovirus immunization after global polio eradication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The persistence of these viruses in immunocompromised individuals may compromise polio eradication efforts.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [107]
In the citing paper
“Recent reports describing highly divergent VDPVs associated with chronic poliovirus infections (10, 69, 88, 90, 113, 123, 216, 223) or with polio outbreaks (84, 169, 177, 226) underscored the earlier concerns and challenged the critical assumption that OPV-derived viruses would not long persist in the community.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“Most RNA viruses have highly mutable genomes that are potentially capable of rapid evolution, many of orders of magnitude faster than the genomes of DNA viruses or cellular organisms (41, 45), and polioviruses are among the most rapidly evolving of all RNA viruses (60, 88, 108, 117, 185, 226).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“Nucleotide substitutions ( > 80% of which in the coding region are to synonymous codons) accumulate at an overall rate of ∼ 1% per year at all sites, and at ∼ 3% per year at synonymous sites (10, 60, 85, 88, 108, 117).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“They also appear to be largely independent of immune selection, as evolution rates are similar during prolonged replication in immunodeficient patients (10, 88, 117, 223) and during widespread circulation (60, 84, 85, 108).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“Other CVID patients developed paralysis several years after receipt of the implicated OPV dose (typically the last dose) (10, 88, 223).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“Symptoms of immunodeficiency typically become evident later in life, usually in the second and third decades, even though prolonged poliovirus infections may have begun years before the diagnosis of CVID (10, 88, 223).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“the neutralizing antigenic sites of iVDPV isolates are frequently highly divergent and variable, and immunodeficient prolonged excretors may be infected with more than one antigenic variant”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [88]
In the citing paper
“Some iVDPV isolates are highly divergent (∼90% VP1 sequence identity to the parental OPV strain), suggesting that the chronic poliovirus infections had persisted for 10 years or more (25, 68).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [25]
In the citing paper
“In the rapidly evolving poliovirus genome (16, 25, 32, 35), variable sites (which represent ∼33% of total VP1 nucleotides, primarily at positions of codon degeneracy) saturate within ∼30 years.”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [25]
In the citing paper
“Such sequence relationships are typical among isolates of locally circulating wild polioviruses (32, 55) and cVDPVs (22) but not among OPV-like or iVDPV isolates from different patients, which generally follow independent pathways of divergence from the vaccine strain (22, 25, 35; R. Park, unpublished results).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [25]
In the citing paper
“The VP1 evolution rate estimated from the slope of the regression line was (2.47 ± 0.69) × 10−2 substitutions per synonymous site per year, approximately 80% of the rate observed for circulating wild type 1 polioviruses (16, 25, 32).”
From Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (2003) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kimura, M. (1980) · Journal of Molecular Evolution · doi:10.1007/bf01731581 · Cited by 29,778
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
The rapid generation of mutation data matrices from protein sequences
Jones, D. T., Taylor, W. R., & Thornton, J. M. (1992) · Computer applications in the biosciences · doi:10.1093/bioinformatics/8.3.275 · Cited by 7,003
RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL
Domingo, E., & Holland, J. J. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.151 · Cited by 1,514
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,267
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Primary Immunodeficiencies
Rosen, F. S., Cooper, M. D., & WEDGWOOD, R. J. P. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408023110506 · Cited by 1,097
Chronic Enteroviral Meningoencephalitis in Agammaglobulinemic Patients
McKinney, R. E., Katz, S. L., & Wilfert, C. M. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.2.334 · Cited by 450
Lederman, H. M., & Winkelstein, J. A. (1985) · Medicine · doi:10.1097/00005792-198505000-00001 · Cited by 411
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 327
Self-citation
Research works printed but not linked: 2
- Más Lago P. Louzará C. Beltrán J. Jacobo M. Palomera R. Circulación de poliovirus en la población infantil de Cuba.Bol. Oficina Sanit. Panam.871975443449
- Sutter R. W. Prevots R. Vaccine-associated paralytic poliomyelitis among immunodeficient persons.Infect. Med.111994426438
Cited by
Sorted by citations
Virology, epidemiology, pathogenesis, and control of enterovirus 71
Solomon, T., Lewthwaite, P., Perera, D., Cardosa, M. J., McMinn, P. C., & Ooi, M. H. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70194-8 · Cited by 1,301
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Self-citationMolecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998
Brown, B. A., Oberste, M. S., Alexander, J. P., Kennett, M., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9969-9975.1999 · Cited by 431
Self-citationFrom Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Nathanson, N., & Kew, O. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq320 · Cited by 412
Self-citationRobinson, C. M., Jesudhasan, P. R. R., & Pfeiffer, J. K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.004 · Cited by 312
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 312
Self-citationCirculating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 257
Self-citationHost and virus determinants of picornavirus pathogenesis and tropism
Whitton, J. L., Cornell, C. T., & Feuer, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1284 · Cited by 249
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Self-citationNatural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., & Crainic, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8434-8443.2000 · Cited by 202
Differential Diagnosis of Acute Flaccid Paralysis and its Role in Poliomyelitis Surveillance
Marx, A., Glass, J. D., & Sutter, R. W. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018041 · Cited by 176
Self-citationRisks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H. S., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 175
Self-citationSutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Self-citationMacLennan, C. A., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martín, J. E.-S., O’Leary, P., Thompson, R. A., Osman, H. K. E., Wood, P. M. D., Minor, P. D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16150-3 · Cited by 162
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Self-citationIshiko, H., Shimada, Y., Yonaha, M., Hashimoto, O., Hayashi, A., Sakae, K., & Takeda, N. (2002) · The Journal of Infectious Diseases · doi:10.1086/339298 · Cited by 152
Casas, I., Palacios, G. F., Trallero, G., Cisterna, D. M., Freire, M. C., & Tenório, A. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2013 · Cited by 149
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Self-citationPolio eradication: the OPV paradox
Dowdle, W. R., De Gourville, E., Kew, O. M., Pallansch, M. A., & Wood, D. J. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.401 · Cited by 144
Self-citationZhang, Y., Wang, D., Yan, D., Zhu, S., Liu, J., Wang, H., Zhao, S., Yu, D., Nan, L., An, J., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02338-09 · Cited by 143
Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Self-citationCombelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Genetic variability and molecular evolution of Hepatitis A virus
Cristina, J., & Costa‐Mattioli, M. (2007) · Virus Research · doi:10.1016/j.virusres.2007.01.005 · Cited by 135
The Role of B Lymphocytes in Coxsackievirus B3 Infection
Mena, I., Perry, C. M., Harkins, S., Rodrı́guez, F., Gebhard, J. R., & Whitton, J. L. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65223-6 · Cited by 134
Bellmunt, A., May, G., Zell, R., Pring-Åkerblom, P., Verhagen, W., & Heim, A. (1999) · Virology · doi:10.1006/viro.1999.0003 · Cited by 128
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119
Self-citationCáceres, V. M., & Sutter, R. W. (2001) · Clinical Infectious Diseases · doi:10.1086/321905 · Cited by 110
Self-citationKhetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O., & Sutter, R. W. (2003) · The Journal of Infectious Diseases · doi:10.1086/379791 · Cited by 110
Self-citationShulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109
Self-citationVaccines, Vaccination, and Vaccinology
Plotkin, S. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374419 · Cited by 109
Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martín, J. E.-S. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005114 · Cited by 107
Halsey, N. A., Pinto, J. A., Espinosa-Rosales, F. J., Faure-Fontenla, M. A., da Silva, E., Khan, A. J., WEBSTER, A. D. B., Minor, P. D., Dunn, G., Asturias, E. J., et al. (2004) · Europe PMC (PubMed Central) · Cited by 106
Self-citationYang, C.-F., Chen, H., Jorba, J. C., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y., Lin, T., Chen, P., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 104
Self-citationBlomqvist, S., Savolainen, C., Laine, P., Hirttiö, P., Lamminsalo, E., Penttilä, E., Jöks, S., Roivainen, M., & Hovi, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4876-4883.2004 · Cited by 104
Enteric Virus Infections and Diarrhea in Healthy and Human Immunodeficiency Virus-Infected Children
Liste, M. B., Natera, I., Suárez, J. A., Pujol, F. H., Liprandi, F., & Ludert, J. E. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.2873-2877.2000 · Cited by 104
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease
Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., & Agol, V. I. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6791-6799.2002 · Cited by 103
Tebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 102
Self-citationReemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.
Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587694 · Cited by 100
Arita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95
Slifka, M. K., Pagarigan, R. R., Mena, I., Feuer, R., & Whitton, J. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2377-2387.2001 · Cited by 95
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Vaccine-Derived Poliomyelitis 12 Years after Infection in Minnesota
DeVries, A., Harper, J. E., Murray, A., Lexau, C., Bahta, L., Christensen, J., Cebelinski, E. A., Fuller, S., Kline, S., Wallace, G. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008677 · Cited by 87
Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 78
Korotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., & Agol, V. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12460-12465.2003 · Cited by 73
Self-citationType B Coxsackieviruses and Their Interactions with the Innate and Adaptive Immune Systems
Kemball, C. C., Alirezaei, M., & Whitton, J. L. (2010) · Future Microbiology · doi:10.2217/fmb.10.101 · Cited by 79
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis
Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.18974-0 · Cited by 73
Laine, P., Savolainen, C., Blomqvist, S., & Hovi, T. (2005) · Journal of General Virology · doi:10.1099/vir.0.80445-0 · Cited by 72
Vaccine-derived poliovirus from long term excretors and the end game of polio eradication
Martín, J. E.-S. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.005 · Cited by 70
Feasibility of Quantitative Environmental Surveillance in Poliovirus Eradication Strategies
Lodder, W. J., Buisman, A., Rutjes, S. A., Heijne, J. C. M., Teunis, P. F. M., & Husman, A. D. R. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07972-11 · Cited by 71
Mechanisms of genetic variation in polioviruses
Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67
Estimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 70
Self-citationIsolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 63
Self-citationA case for developing antiviral drugs against polio
Collett, M. S., Neyts, J. H., & Modlin, J. F. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.04.002 · Cited by 66
Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
Martín, J. E.-S., Odoom, J. K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., BUTLER, K. M., Hall, W. W., & Minor, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13839-13847.2004 · Cited by 63
Li, L., Ivanova, O., Driss, N., Tiongco-Recto, M., da Silva, R., Shahmahmoodi, S., Sazzad, H. M. S., Mach, O., Kahn, A.-L., & Sutter, R. W. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu065 · Cited by 63
Self-citationYakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ap, I., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., & Agol, V. I. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2641-2653.2006 · Cited by 62
Dowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61
Self-citationRhinovirus Genome Variation during Chronic Upper and Lower Respiratory Tract Infections
Tapparel, C., Cordey, S., Junier, T., Farinelli, L., Belle, S. V., Soccal, P. M., Aubert, J., Zdobnov, E. M., & Kaiser, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021163 · Cited by 60
Poliovirus Infections in Four Unvaccinated Children--Minnesota, August-October 2005
(2005) · JAMA · doi:10.1001/jama.294.21.2689 · Cited by 58
Immunopathology during coxsackievirus infection
Whitton, J. L. (2002) · Springer Seminars in Immunopathology · doi:10.1007/s00281-002-0100-4 · Cited by 57
Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1062-1070.2005 · Cited by 55
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 55
Self-citationIsolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
Zurbriggen, S., Tobler, K., Abril, C. E., Diedrich, S., Ackermann, M., Pallansch, M. A., & Metzler, A. E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-07 · Cited by 55
Self-citationKlingel, K., Schnorr, J., Sauter, M., Szalay, G., & Kandolf, R. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64305-2 · Cited by 53
Shaghaghi, M., Soleymanjahi, S., Abolhassani, H., Yazdani, R., Azizi, G., Rezaei, N., Barbouche, M., McKinlay, M. A., & Aghamohammadi, A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.059 · Cited by 51
Lago, P. M., Cáceres, V. M., Galindo, M. A., Gary, H. E., Valcárcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A., Palomera, R., et al. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1029 · Cited by 49
Self-citationThe Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
Andino, R., Kirkegaard, K., Macadam, A. J., Racaniello, V. R., & Rosenfeld, A. B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac426 · Cited by 53
Zhang, L., Parham, N. J., Zhang, F., Aasa-Chapman, M. M. I., Gould, E. A., & Zhang, H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.061 · Cited by 48
Macklin, G., Liao, Y., Takane, M., Dooling, K., Gilmour, S., Mach, O., Kew, O. M., Sutter, R. W., & The iVDPV Working Group (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01103 · Cited by 47
Self-citationAlthof, N., Harkins, S., Kemball, C. C., Flynn, C. T., Alirezaei, M., & Whitton, J. L. (2014) · Journal of Virology · doi:10.1128/jvi.00184-14 · Cited by 47
The Bumpy Road to Polio Eradication
Modlin, J. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1005405 · Cited by 46
Tebbens, R. J. D., Pallansch, M. A., & Thompson, K. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1115-5 · Cited by 46
Self-citationChen, Z., Chumakov, K., Dragunsky, E. M., Kouiavskaia, D. V., Makiya, M. A., Neverov, A., Rezapkin, G. V., Sebrell, A., & Purcell, R. H. (2011) · Journal of Virology · doi:10.1128/jvi.02553-10 · Cited by 46
Shahmahmoodi, S., Parvaneh, N., Burns, C. C., Asghar, H., Mamishi, S., Tabatabaie, H., Chen, Q., Teimourian, S., Gooya, M. M., Esteghamati, A., et al. (2008) · Virus Research · doi:10.1016/j.virusres.2008.07.006 · Cited by 44
Self-citationA Spread-Deficient Cytomegalovirus for Assessment of First-Target Cells in Vaccination
Mohr, H., Arapović, J., Mühlbach, H., Panzer, M., Weyn, A., Dölken, L., Krmpotić, A., Voehringer, D., Ruzsics, Z., Koszinowski, U. H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02696-09 · Cited by 44
Progress towards global polio eradication
Hull, H. F., & Aylward, R. B. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00144-x · Cited by 43
Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., & Martín, J. E.-S. (2008) · Journal of Virology · doi:10.1128/jvi.00468-08 · Cited by 42
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method
Nix, W. A., Berger, M. M., Oberste, M. S., Brooks, B. R., McKenna‐Yasek, D., Brown, R. H., Roos, R. P., & Pallansch, M. A. (2004) · Neurology · doi:10.1212/01.wnl.0000123258.86752.51 · Cited by 43
Self-citationGlobal Polio Eradication – Way Ahead
Bahl, S. K., Bhatnagar, P., Sutter, R. W., Roesel, S., & Zaffran, M. (2018) · The Indian Journal of Pediatrics · doi:10.1007/s12098-017-2586-8 · Cited by 44
Self-citationThe role of routine polio immunization in the post-certification era.
Sutter, R. W., Cáceres, V. M., & Lago, P. M. (2004) · Europe PMC (PubMed Central) · Cited by 40
Self-citationInnate and adaptive immune responses against picornaviruses and their counteractions: An overview
Dotzauer, A. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i3.91 · Cited by 40
Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses
Kilpatrick, D. R., Ching, K., Iber, J., Campagnoli, R., Freeman, C. J., Mishrik, N., Liu, H.-M., Pallansch, M. A., & Kew, O. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4313-4315.2004 · Cited by 39
Self-citationThe Vaccine Origin of the 1968 Epidemic of Type 3 Poliomyelitis in Poland
Martín, J. E.-S., Ferguson, G. L., Wood, D. J., & Minor, P. D. (2000) · Virology · doi:10.1006/viro.2000.0614 · Cited by 37
Transitions in Understanding of RNA Viruses: A Historical Perspective
Holland, J. J. (2006) · Springer eBooks · doi:10.1007/3-540-26397-7_14 · Cited by 39
Archimbaud, C., Bailly, J., Chambon, M., Tournilhac, O., Travade, P., & Peigue‐Lafeuille, H. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4605-4610.2003 · Cited by 38
Driss, N., Ben‐Mustapha, I., Mellouli, F., Yahia, A. B., Touzi, H., Béjaoui, M., Ghorbel, M. B., Triki, H., & Barbouche, M. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00293-12 · Cited by 37
Poliovirus vaccination during the endgame: insights from integrated modeling
Tebbens, R. J. D., & Thompson, K. M. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1322514 · Cited by 35
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“These individuals may represent a potential source of virus reintroduction once the disease is eradicated [107,108].”
BackgroundPoliovirus Vaccines: Molecular Biology and Immune Response
Minor, P. D., & Almond, J. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch30 · Cited by 33
Genus-Specific Substitution Rate Variability among Picornaviruses
Hicks, A. L., & Duffy, S. (2011) · Journal of Virology · doi:10.1128/jvi.02535-10 · Cited by 35
Zhang, Y., Yan, D., Zhu, S., Wen, N., Li, L., Wang, H., Liu, J., Ye, X., Ding, Z., Wang, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657410 · Cited by 34
Self-citationLabadie, K., Pelletier, I., Saulnier, A., Martín, J. E.-S., & Colbère-Garapin, F. (2003) · Virology · doi:10.1016/j.virol.2003.09.005 · Cited by 33
Tao, Z., Wang, H., Xu, A., Zhang, Y., Song, L., Zhu, S., Li, Y., Yan, D., Liu, G., Yoshida, H., et al. (2010) · Virus Research · doi:10.1016/j.virusres.2010.02.014 · Cited by 33
An Echovirus Type 33 Winter Outbreak in New Zealand
Huang, Q. S., Carr, J. M., Nix, W. A., Oberste, M. S., Kilpatrick, D. R., Pallansch, M. A., Croxson, M. C., Lindeman, J., Baker, M. G., & Grimwood, K. (2003) · Clinical Infectious Diseases · doi:10.1086/376915 · Cited by 33
Self-citationde Silva, R., Gunasena, S., Ratnayake, D., Wickremesinghe, G. D., Kumarasiri, C., Pushpakumara, B. A. W., Deshpande, J. M., Kahn, A.-L., & Sutter, R. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.035 · Cited by 32
Self-citationViral infection in primary antibody deficiency syndromes
Jones, T. P., Buckland, M. S., Breuer, J., & Lowe, D. M. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2049 · Cited by 32
Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant
Dedepsidis, E., Pliaka, V., Kyriakopoulou, Z., Brakoulias, C., Levidiotou-Stefanou, S., Pratti, A., Mamuris, Z., & Markoulatos, P. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00381.x · Cited by 32
Samoilovich, E., Roivainen, M., Titov, L. P., & Hovi, T. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10480 · Cited by 30
Bailly, J., Chambon, M., Henquell, C., Icart, J., & Peigue‐Lafeuille, H. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.552-557.2000 · Cited by 32
Metadata
- Authors
- Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A.
- Affiliations
- National Center for Infectious Diseases (US)
- <!--label omitted: 2-->Divisions of Eradication of Vaccine-Preventable Diseases2 and
- Centers for Disease Control and Prevention (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 1998-10
- Volume
- 36
- Issue
- 10
- Pages
- 2893-2899
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC105084
- OpenAlex
- W2159041114
- Cited by
- 213
- References
- 36
- Citations by year
- 2024: 4 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 9 · 2016: 4 · 2015: 3 · 2014: 16 · 2013: 6 · 2012: 14
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- poliovirus type 1, vaccine-derived poliovirus, common variable immunodeficiency, viral evolution, poliomyelitis, oral polio vaccine, polio eradication
- MeSH terms
- Adult, Amino Acid Sequence, Base Sequence, Capsid, Child, Feces, Follow-Up Studies, Humans, Immunologic Deficiency Syndromes, Male, Molecular Sequence Data, Phylogeny, Viral Plaque Assay, Poliomyelitis, Poliovirus Vaccine, Oral, RNA, Viral, Genetic Variation, Virus Replication, Polymerase Chain Reaction, Sequence Alignment, Sequence Homology, Amino Acid, Poliovirus, Evolution, Molecular, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
